Ho Wah Genting gets NPRA approval for health supplement


KUALA LUMPUR: Ho Wah Genting Bhd (HWGB) has obtained a full pharmaceutical product registration approval for its wholly-owned subsidiary, Astramern Sdn Bhd’s health supplement, Astramern Astra H, from the National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health.

The Astramern Astra H comes in capsule form and contains specially formulated Chinese herbs that help to boost the body’s immune system to fight off germs, said HWGB.

The NPRA’s full approval for the health supplement and traditional medicine is granted for the maximum period of five years and renewable thereof, it said in a statement here today.

"This approval is key in getting the Astramern Astra H dietary supplement into the market for distribution,” HWGB Biotech’s general manager, medical & pharmaceutical research, Dr Yaman Walid Kassab said.

According to the company, the key ingredient of the health supplement is the Astragalus extract, which is commonly known for its efficacy in traditional Chinese medicine.

The Astramen Astra H also contains ginger root extract that is high in gingerol and also licorice extract which have properties to soothe stomach ailments, cleanses the respiratory system while also able to ease the pressure from stress and complement cancer treatment, it added.

As part of HWGB’s diversification plan to move into the healthcare business, the approval by the NPRA is the next milestone after the appointment of San Diego-based and Nasdaq-listed Guardion Health Sciences Inc (GHSI) to design and manufacture two health supplements, Astramern Nutra V and Astramern Astra H, it added. - Bernama
Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3

Ho Wah Genting , Supplement , NPRA

   

Did you find this article insightful?

Yes
No

100% readers found this article insightful

Next In Business News

CPO futures trading to remain range bound next week
Advisory panel unanimously recommends FDA authorize Johnson & Johnson COVID-19 vaccine
GameStop rally fizzles; shares still register 151% weekly gain
NYSE begins move to delist Chinese state oil producer CNOOC
Oil price drops on US$ strength and OPEC+ supply expectations
GLOBAL MARKETS-Globals stock slide on inflation fears
AMMB says it has enough capital to absorb 1MDB global settlement�
A five-year high for FGV Holdings
AMMB to pay RM2.83bil to the government
IHH to take proactive measures

Stories You'll Enjoy


Vouchers